RxDoctor Payments Data

Terri Weber

Physician Assistant · Wagram, NCNPI 1235695230

Payments from drug & device makers

$2,527in general payments, 2019–2025

Across 138 payments — averaging $18.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$711
  • Novo Nordisk$330
  • Boehringer Ingelheim$221
  • AbbVie$206
  • Exact Sciences$168
  • Lilly USA, LLC$163
  • plus $727 from 19 others

What the payments were for

  • Food & beverage$2,51399%
  • Education$141%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,527 in reported general payments places this provider in the 80th percentile of 7,441 physician assistant providers in North Carolina.

See all physician assistant providers in North Carolina

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide91$101,705
OzempicSemaglutide49$63,706
LinzessLinaclotide46$47,652
FarxigaDapagliflozin Propanediol25$30,951
EliquisApixaban38$28,459
Tresiba Flextouch U-100Insulin Degludec46$23,841
TrulicityDulaglutide20$23,665
RybelsusSemaglutide13$21,245
JardianceEmpagliflozin16$18,704
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog22$14,869
Repatha SureclickEvolocumab19$14,473
Trelegy ElliptaFluticasone/Umeclidin/Vilanter12$14,072
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr13$7,011
Breo ElliptaFluticasone/Vilanterol13$5,591
SymbicortBudesonide/Formoterol Fumarate21$4,903

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity$163$125,370111 claims
Novo NordiskOzempic, Rybelsus$330$84,95162 claims
AbbVieLinzess$206$47,65246 claims
AstraZenecaFarxiga, Symbicort$711$35,85446 claims
GSKTrelegy Ellipta, Anoro Ellipta, Breo Ellipta, Shingrix$31$30,12056 claims
PfizerEliquis$64$28,45938 claims
Boehringer IngelheimJardiance$221$18,70416 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 7,441 physician assistant providers in North Carolina.

Other physician assistant in Wagram

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →